Weiran Cao
Adult Health · City Of Industry, CANPI 1720315443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 322 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,699 and has fallen 53.6% since, to $789 in 2025. Among adult health clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 322 payments — averaging $20.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$903
- Bayer$728
- Novo Nordisk$724
- Amgen$630
- GSK$558
- Boehringer Ingelheim$518
- plus $3K from 30 others
What the payments were for
- Food & beverage$6,662100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 39 | $903 |
| Bayer | 25 | $728 |
| Novo Nordisk | 53 | $724 |
| Amgen | 35 | $630 |
| GSK | 25 | $558 |
| Boehringer Ingelheim | 21 | $518 |
| Radius Health, Inc. | 10 | $258 |
| Ironwood Pharmaceuticals, Inc | 9 | $211 |
| Esperion Therapeutics, Inc. | 7 | $154 |
| Novartis | 6 | $152 |
| Johnson & Johnson | 12 | $149 |
| Amarin Pharma, Inc. | 7 | $142 |
| Exact Sciences | 5 | $138 |
| Scilex Pharmaceuticals Inc. | 6 | $119 |
| Nestle Healthcare Nutrition Inc. | 5 | $111 |
| AstraZeneca | 5 | $110 |
| Sumitomo Pharma America, Inc. | 5 | $110 |
| Redhill Biopharma Inc. | 6 | $109 |
| Dexcom, Inc. | 5 | $93 |
| Merck | 5 | $93 |
| Astellas Pharma US Inc | 4 | $74 |
| AbbVie | 3 | $71 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Pfizer | 2 | $46 |
| Vivus LLC | 2 | $45 |
| Sunovion Pharmaceuticals Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Corium, LLC | 1 | $30 |
| Alvogen Inc | 1 | $27 |
| Almatica Pharma LLC | 1 | $25 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Biogen | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$6,662 in reported general payments places this provider in the 90th percentile of 785 adult health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VascepaIcosapent Ethyl | 15 | $7,876 |
| Icosapent Ethyl | 15 | $2,762 |
| Lidocaine | 18 | $951 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 16 | $523 |
| Nebivolol Hcl | 13 | $443 |
| Fluocinonide | 11 | $401 |
| Megestrol Acetate | 16 | $227 |
| Losartan Potassium | 17 | $166 |
| Atorvastatin Calcium | 29 | $155 |
| Amlodipine Besylate | 36 | $118 |
| Hydrocortisone | 19 | $110 |
| Fluticasone Propionate | 15 | $83 |
| Olmesartan Medoxomil | 16 | $73 |
| Omeprazole | 20 | $63 |
| Dutasteride | 12 | $58 |
Paid to pharmacies, not to this prescriber.
Other adult health in City Of Industry
- Karolina FaysmanLos Angeles$1.1M
- Linda BuckLos Angeles$170K
- Naomi PesynaAnaheim$141K
- Stacy GrissenEncinitas$82K
- Kimberly PodsadaSan Diego$78K
- Brenda PatrickSan Leandro$68K
- Brittany PolizziEncinitas$35K
- Nancy NicolosiLaguna Woods$31K
- Michele WestendorfNewport Beach$30K
- Lisa HinemanLos Angeles$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.